Novartis announced it broke ground for the expansion of its biopharmaceutical manufacturing plant in Singapore. The US$256 million investment will facilitate Novartis in deploying digital and automation solutions to enhance manufacturing productivity, improve operational efficiency, and upskill the workforce. The expanded site will focus on manufacturing therapeutic antibody drugs to deliver breakthrough treatments to patients globally, a statement…
Novartis Board of Directors announced the appointment of Gilbert Ghostine as Chairman-designate of the new Board of Directors of Sandoz. Ghostine has served as CEO of Geneva-based Firmenich, the world’s largest privately owned perfume and taste company, since 2014. Gilbert Ghostine will become Chairman of the New Board of Directors of Sandoz, which will be…
Novartis India is planning to layoff 170 employees as part of its workforce rationalization due to the COVID pandemic. “The layoff plan has been drawn as part of ‘fit for future’ project. The communication to identified employees will be made by March 31,” as shared by a senior executive. A spokesperson of Novartis informed, “Novartis…
Sai Life Sciences, a Contract Research, Development & Manufacturing Organization (CRDMO), has announced the addition of Dr. Mahavir Prashad to its scientific leadership team as Vice President of Early Phase Process Development. With over three decades of experience in advanced research, and roles of increasing responsibility in a pharmaceutical company, Dr. Prashad will provide impetus…
The drug company, Novartis India has announced that its India Managing Director and Chairman, Milan Paleja has resigned and has decided to step down from the company, with effect from May 31, 2019. “We wish to inform you that, Mr Milan Paleja, Vice Chairman & Managing Director of the Company has informed the Board of…
Novartis International AG, a Swiss multinational pharmaceutical company based in Basel, will cut around 2,550 jobs in Switzerland and UK over the next 4 years as the pharmaceutical firm is planning to boost its revenue and focus on new medicines. It is one of the largest pharmaceutical companies by both market capitalization and sales. The Swiss drugmaker…